Skip to content

Company information lookup

STARPHARMA HOLDINGS LIMITED (SPL)

Biotechnology - development of dendrimer technology for pharmaceutical, life science and other applications.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
SPL 0.642 -3.46% 0.640 0.645 0.665 0.680 0.640 327,368

STARPHARMA HOLDINGS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code SPL
Securities
Official Listing Date 28 September, 2000
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.starpharma.com
Registered Office Address Baker IDI Building, 75 Commercial Road, MELBOURNE, VIC, AUSTRALIA, 3004
Head Office Telephone (03) 8532 2700
Head Office Fax (03) 9510 5955
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Robert Thomas (Non Exec. Chairman)
Dr Jackie Fairley (Managing Director, CEO)
Mr Richard Hazleton (Non Exec. Director)
Dr Peter Jenkins (Non Exec. Director)
Ms Zita Peach (Non Exec. Director)
Mr Peter Turvey (Non Exec. Director)
Mr Nigel Baade (CFO)
Company Secretary Mr Nigel Baade
Principal Activities Biotechnology - development of dendrimer technology for pharmaceutical, life science and other applications.

STARPHARMA HOLDINGS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
21/10/2014   Starpharma Boardroom Radio Interview 2 PDF
20/10/2014   Extension of Share Purchase Plan 2 PDF
20/10/2014 asterix DEP docetaxel - longer duration and increased exposure 4 PDF
16/10/2014   Notice of Annual General Meeting/Proxy Form 18 PDF
14/10/2014   Change of Director's Interest Notice 3 PDF
14/10/2014   Appendix 3B 8 PDF
14/10/2014   Starpharma to present at US Drug Delivery Conference 2 PDF
07/10/2014   Shareholder Update October 2014 4 PDF
03/10/2014   Change in substantial holding 2 PDF
02/10/2014 asterix VivaGel condom approved for sale with launch imminent 3 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
21 Oct 2014 0.665 -0.75% 0.675 0.660 384,527
20 Oct 2014 0.670 3.88% 0.695 0.650 269,186
17 Oct 2014 0.645 0.78% 0.655 0.640 253,692
16 Oct 2014 0.640 0.79% 0.645 0.635 114,088
15 Oct 2014 0.635 -2.31% 0.645 0.635 101,326

* Volume of shares shown represents only those shares traded on ASX.

STARPHARMA HOLDINGS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security SPL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security SPL

Warrants & Structured Products

No warrants & Structured Products are available over the security SPL